Institution profile

医療法人社団医新会 神田医新クリニック

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 02C2407018 +4

Location

Prefecture
Tokyo
Address
千代田区岩本町2-2-13

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 日本臨床幹細胞研究会 特定認定再生医療等委員会
  • JSCSF再生医療等委員会
  • ICTA特定認定再生医療等委員会

Public score

57.3/ 100

A · Review level
25.0 / 30
B · Technologies
20.6 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
4.6 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 255of 1736

Registered technologies
5
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 57.3
Public score →100

Registered technologies (5)

Stem cells (all sources) 2
Registered technologies · Japanese originalTechnology areasPlan classification
更年期障害に対する自己脂肪由来間葉系幹細胞による点滴療法Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたフレイルおよびプレフレイルの治療Stem cells (all sources)Adipose-derived stem cellsClass II
Adipose-derived stem cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
更年期障害に対する自己脂肪由来間葉系幹細胞による点滴療法Stem cells (all sources)Adipose-derived stem cellsClass II
自己脂肪由来幹細胞を用いたフレイルおよびプレフレイルの治療Stem cells (all sources)Adipose-derived stem cellsClass II
NK and immune cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
ヒト自己活性化NK細胞によるがん免疫細胞療法NK and immune cellsClass III
ヒト自己活性化αβT細胞によるがん免疫細胞療法NK and immune cellsClass III
ヒト自己活性化γδT細胞によるがん免疫細胞療法NK and immune cellsClass III

Certified committee for regenerative medicine

  • 日本臨床幹細胞研究会 特定認定再生医療等委員会
  • JSCSF再生医療等委員会
  • ICTA特定認定再生医療等委員会

Public document number

  • 02C2407018
  • 01C2506024
  • 02C2112015
  • 02C2112016
  • 02C2112017
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
更年期障害に対する自己脂肪由来間葉系幹細胞による点滴療法Class II日本臨床幹細胞研究会 特定認定再生医療等委員会02C2407018
自己脂肪由来幹細胞を用いたフレイルおよびプレフレイルの治療Class IIJSCSF再生医療等委員会01C2506024
ヒト自己活性化NK細胞によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会02C2112015
ヒト自己活性化αβT細胞によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会02C2112016
ヒト自己活性化γδT細胞によるがん免疫細胞療法Class IIIICTA特定認定再生医療等委員会02C2112017

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor